These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 10225447)

  • 1. Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes.
    Ferrarini M; Imro MA; Sciorati C; Heltai S; Protti MP; Pellicciari C; Rovere P; Manfredi AA; Rugarli C
    Int J Cancer; 1999 May; 81(4):573-9. PubMed ID: 10225447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
    J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Fas and granule exocytosis pathways in tumor-infiltrating T lymphocyte-induced apoptosis of autologous human lung-carcinoma cells.
    Dorothee G; Ameyar M; Bettaieb A; Vergnon I; Echchakir H; Bouziane M; Chouaib S; Mami-Chouaib F
    Int J Cancer; 2001 Mar; 91(6):772-7. PubMed ID: 11275978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
    Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
    J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
    Yang S; Haluska FG
    J Immunol; 2004 Apr; 172(7):4599-608. PubMed ID: 15034078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of Fas-mediated cytotoxicity and FasL expression in a cytotoxic CD4+ T-cell clone. Comparative analysis of Fas-mediated cytotoxicity between a T-hybridoma and a T-cell clone.
    Kaneda R; Iwabuchi K; Onoé K
    Immunol Lett; 1997 Jan; 55(1):53-60. PubMed ID: 9093882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes.
    Hallermalm K; De Geer A; Kiessling R; Levitsky V; Levitskaya J
    Cancer Res; 2004 Sep; 64(18):6775-82. PubMed ID: 15374996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent downregulation of Fas (CD95) expression and function in melanoma.
    Bullani RR; Wehrli P; Viard-Leveugle I; Rimoldi D; Cerottini JC; Saurat JH; Tschopp J; French LE
    Melanoma Res; 2002 Jun; 12(3):263-70. PubMed ID: 12140383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
    Hahne M; Rimoldi D; Schröter M; Romero P; Schreier M; French LE; Schneider P; Bornand T; Fontana A; Lienard D; Cerottini J; Tschopp J
    Science; 1996 Nov; 274(5291):1363-6. PubMed ID: 8910274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas receptor (CD95)-mediated apoptosis in leukemic cells.
    Komada Y; Sakurai M
    Leuk Lymphoma; 1997 Mar; 25(1-2):9-21. PubMed ID: 9130610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand.
    von Bernstorff W; Spanjaard RA; Chan AK; Lockhart DC; Sadanaga N; Wood I; Peiper M; Goedegebuure PS; Eberlein TJ
    Surgery; 1999 Jan; 125(1):73-84. PubMed ID: 9889801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional significance of adhesion molecules in Fas-dependent apoptotic cell death induced by interleukin-2-activated T cells.
    Zhou YW; Komada Y; Inaba H; Deguchi T; Sugiyama K; Azuma E; Sakurai M
    Immunol Invest; 1998; 27(4-5):309-22. PubMed ID: 9730091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition.
    Zaks TZ; Chappell DB; Rosenberg SA; Restifo NP
    J Immunol; 1999 Mar; 162(6):3273-9. PubMed ID: 10092779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2+ signaling modulates cytolytic T lymphocyte effector functions.
    Esser MT; Haverstick DM; Fuller CL; Gullo CA; Braciale VL
    J Exp Med; 1998 Apr; 187(7):1057-67. PubMed ID: 9529322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zeta-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways.
    Zhong L; Wu CH; Lee WH; Liu CP
    J Immunol; 2004 Feb; 172(3):1472-82. PubMed ID: 14734724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors.
    Poggi A; Massaro AM; Negrini S; Contini P; Zocchi MR
    J Immunol; 2005 Mar; 174(5):2653-60. PubMed ID: 15728472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.
    Favre-Felix N; Fromentin A; Hammann A; Solary E; Martin F; Bonnotte B
    J Immunol; 2000 May; 164(10):5023-7. PubMed ID: 10799856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Fas- versus perforin-mediated pathways of cytotoxicity in TCR- and Thy-1-activated murine T cells.
    Kojima H; Toda M; Sitkovsky MV
    Int Immunol; 2000 Mar; 12(3):365-74. PubMed ID: 10700471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases.
    Caldwell SA; Ryan MH; McDuffie E; Abrams SI
    J Immunol; 2003 Sep; 171(5):2402-12. PubMed ID: 12928387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.